On Monday, June 17, Lisa Gora testified before the New Jersey Assembly Health, Human Services and Senior Citizens Committee at the State House in Trenton, New Jersey, before Chairman and Assemblyman Herb Conaway, M.D., and 10 New Jersey legislators in support of A 3852, the Psilocybin Behavioral Health Access and Services Act.
The majority of the Assembly members approved this bill's advancement and adoption, causing it to move forward in the legislative process.
This bill authorizes the production and use of psilocybin by patients after an assessment by a licensed health care practitioner that such a patient, based on a clinical assessment, would benefit from the therapeutic use of psilocybin. The bill would charge the New Jersey Department of Health with licensing and regulating the manufacture, testing, transport, delivery, sale, and purchase of psilocybin and create a psilocybin service center / wellness clinic whereby licensed health care practitioners would be permitted to refer patients to receive psilocybin treatment at a psilocybin service center after an assessment and diagnosis by a licensed health care practitioner.
The bill also requires the creation of a Psilocybin Advisory Board that would establish qualifying medical conditions for use, propose guidelines for psilocybin services and dosage, craft safety screenings and informed consent practices, and oversee facilitator education, training, and conduct. Its stated goal would be to develop a long-term strategic plan for safe, accessible, and affordable access to psilocybin for patients with particular symptoms, conditions, and diagnoses.
Results may vary depending on your particular facts and legal circumstances.
People
- Member of the Firm